Forensic Technology Center of Excellence


MDI Considerations for Prescription Drug Monitoring Programs

MDI Considerations for Prescription Drug Monitoring Programs

← Back to MDI Webinar Series

Thursday, November 4th, 2021 | 1:00 - 2:00 PM ET
Duration: 1 hour

Medical examiners and coroners use a variety of data sources to complete a medicolegal death investigation (MDI) and make determinations on a cause and manner of death. One of those data sources is state prescription drug monitoring programs (PDMPs). PDMPs are state-operated databases and medicolegal surveillance systems that document the dispensing of certain prescription medications to individual patients. Typically, PDMPs aggregate transactional records of controlled substance prescriptions when dispensed in outpatient pharmacy settings. This means that a patient receives the medication for in-home use rather than being administered the medication directly by a healthcare provider within a medical facility, such as a hospital or clinic. This information can provide critical details on a patient’s history of treatment for substance use disorder, predicted opioid tolerance, prescribers/dispensers of last contact, unusual drug utilization patterns, and other investigative clues.

Also, medical examiners'/coroners' (ME/C's) use of PDMPs may itself be an area of new research. For example, how much time does an ME/C save during an investigation by using PDMP data? Can tools specific to the ME/C community be developed by PDMPs? Does tracking ME/C's use of the PDMPs provide any insight or value to understanding the substance use epidemic? The answers to these questions could provide valuable information to the MDI community and other stakeholders.

Detailed Learning Objectives:
Attendees will be able to:
1.) Identify how ME/Cs use PDMP data for a medicolegal death investigation.
2.) Understand how ME/Cs access PDMPs, how access of PDMPs is tracked in state databases, and what methods exist for quantifying measures of use.
3.) Gain awareness of new opportunities and barriers for research on ME/C's use of PDMPs.

Chris Delcher, Ph.D. | Epidemiologist and Associate Professor in the Department of Pharmacy Practice and Science & Director of the Institute for Pharmaceutical Outcomes and Policy at the University of Kentucky

Register Here

Funding for this Forensic Technology Center of Excellence event has been provided by the National Institute of Justice.

Each of our webinars is archived within about two weeks of the live date and will be posted on our website.

Please contact us at for any questions.

Please subscribe to our newsletter for notifications.

Related Content

2019 National Institute of Justice Forensic Science Research and Development Symposium

This report was published in RTI Press, a global publisher of peer-reviewed, open-access publications on a broad range of topics. The areas of focus reflect RTI’s multidisciplinary research, our expertise in social and laboratory sciences, and our extensive international activities. Since…

Success Story: Uncovering Key Details of Skeletal Remains through 3D-ID Software

NIJ and North Carolina State University Report Date January 2019 Impact “3D-ID has been an invaluable tool for us. Many of our unknown persons come from populations south of the Border. We use this program for every case with great…

Strengthening the Medical Examiner–Coroner System Through NIJ-funded Programs: 2018 Medicolegal Death Investigation Stakeholders’ Meeting

Report Date September 2018 Report Summary On February 5–6, 2018, the National Institute of Justice (NIJ), the research and evaluation agency of the United States Department of Justice (DOJ), convened a diverse group of stakeholders from across the United States…